[CAS NO. 470-17-7]  Isoalantolactone

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [470-17-7]

Catelog
SLK-S3829
Brand
Selleck
CAS
470-17-7

DESCRIPTION [470-17-7]

Overview

MDLMFCD08689940
Molecular Weight232.32
Molecular FormulaC15H20O2
SMILESC[C@]12[C@@](C[C@]3([C@@](C1)(OC(=O)C3=C)[H])[H])(C(=C)CCC2)[H]

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM4.3044 mL21.5220 mL43.0441 mL
5 mM0.8609 mL4.3044 mL8.6088 mL
10 mM0.4304 mL2.1522 mL4.3044 mL
50 mM0.0861 mL0.4304 mL0.8609 mL

Description

Isoalantolactone, one of the major sesquiterpene lactone compounds, is isolated from the roots of Anula helenium and possesses multiple biological activities including antifungal, anthelmintic, antimicrobial, anti-inflammatory, antitrypanosomal activities and antiproliferative effects on several cancer cell lines, such as colon, melanoma, ovary, prostate, lung, and leukemia. Isoalantolactone is an apoptosis inducer, which also acts as an alkylating agent.

In vitro

Isoalantolactone inhibits growth and induces apoptosis in pancreatic cancer cells. Isoalantolactone increases the expression of phosphorylated p38 MAPK, Bax, and cleaved caspase-3 and decreases the expression of Bcl-2 in a dose-dependent manner. Isoalantolactone treatment in HeLa cancer cells exhibits cytotoxicity in a dose-dependent manner with a low IC50 value of 8.15 ± 1.16 μM.

In vivo

Isoalantolactone does not induce any acute or chronic toxicity in liver and kidneys of CD1 mice at dose of 100 mg/kg body weight. Isoalantolactone is distributed and eliminated rapidly possibly due to its low-polarity characteristic. A large apparent volume of distribution (138.44 ± 54.14 L) suggests that the lactones may accumulate in certain organs with high concentration after intravenous injection.


Synonyms

Naphtho[2,3-b]furan-2(3H)-one, decahydro-8a-methyl-3,5-bis(methylene)-, (3aR,4aS,8aR,9aR)-
Eudesma-4(14),11(13)-dien-12-oic acid, 8β-hydroxy-, γ-lactone
Isoalantolactone
Naphtho[2,3-b]furan-2(3H)-one, decahydro-8a-methyl-3,5-bis(methylene)-, [3aR-(3aα,4aα,8aβ,9aα)]-
(3aR,4aS,8aR,9aR)-Decahydro-8a-methyl-3,5-bis(methylene)naphtho[2,3-b]furan-2(3H)-one
(+)-Isoalantolactone
Isoallantolactone
Isohelenin
H-Eudesma-4(15),11(13)-dien-12,8β-olide
NSC 241036